Notice2021-15507
Twelfth Meeting of the National Clinical Care Commission
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
July 21, 2021
Issuing agencies
Health and Human Services Department
Abstract
The National Clinical Care Commission (the Commission) will conduct its twelfth and final meeting virtually on September 8, 2021. The Commission is charged to evaluate and make recommendations to the U.S. Department of Health and Human Services (HHS) Secretary and Congress regarding improvements to the coordination and leveraging of federal programs related to diabetes and its complications.
Full Text
<html>
<head>
<title>Federal Register, Volume 86 Issue 137 (Wednesday, July 21, 2021)</title>
</head>
<body><pre>
[Federal Register Volume 86, Number 137 (Wednesday, July 21, 2021)]
[Notices]
[Page 38492]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2021-15507]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Twelfth Meeting of the National Clinical Care Commission
AGENCY: Office on Women's Health, Office of the Assistant Secretary for
Health, Office of the Secretary, Department of Health and Human
Services.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The National Clinical Care Commission (the Commission) will
conduct its twelfth and final meeting virtually on September 8, 2021.
The Commission is charged to evaluate and make recommendations to the
U.S. Department of Health and Human Services (HHS) Secretary and
Congress regarding improvements to the coordination and leveraging of
federal programs related to diabetes and its complications.
DATES: The final meeting will take place September 8, 2021 from 1 p.m.
to approximately 6 p.m. Eastern Time (ET).
ADDRESSES: The meeting will be held online via webinar. To register to
attend the meeting, please visit the registration website at <a href="https://kauffmaninc.adobeconnect.com/nccc12_2021/event/event_info.html">https://kauffmaninc.adobeconnect.com/nccc12_2021/event/event_info.html</a>.
FOR FURTHER INFORMATION CONTACT: Kara Elam, Ph.D., MPH, MS, Designated
Federal Officer, National Clinical Care Commission, U.S. Department of
Health and Human Services, Office on Women's Health, 200 Independence
Ave. SW, 7th floor, Washington DC, 20201, Phone: (240) 435-9438, Email:
<a href="/cdn-cgi/l/email-protection#5813392a39761d3439351830302b763f372e"><span class="__cf_email__" data-cfemail="df94beadbef19ab3beb29fb7b7acf1b8b0a9">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: The National Clinical Care Commission Act
(Pub. L. 115-80) requires the HHS Secretary to establish the National
Clinical Care Commission. The Commission consists of representatives of
specific federal agencies and non-federal individuals who represent
diverse disciplines and views. The Commission will evaluate and make
recommendations to the HHS Secretary and Congress regarding
improvements to the coordination and leveraging of federal programs
related to diabetes and its complications.
During the meeting, the Commission will vote to approve the final
report to be submitted to Congress. The final meeting agenda will be
available prior to the meeting at <a href="https://health.gov/our-work/health-care-quality/national-clinical-care-commission/meetings">https://health.gov/our-work/health-care-quality/national-clinical-care-commission/meetings</a>.
Public Participation at Meeting: The Commission invites public
comment on issues related to the Commission's charge. There will be an
opportunity for limited oral comments (each no more than 3 minutes in
length) at this virtual meeting. Virtual attendees who plan to provide
oral comments at the Commission meeting during a designated time must
register prior to the meeting at <a href="https://kauffmaninc.adobeconnect.com/nccc12_2021/event/event_info.html">https://kauffmaninc.adobeconnect.com/nccc12_2021/event/event_info.html</a>.
Written comments are welcome throughout the entire development
process of the Commission's work and may be emailed to <a href="/cdn-cgi/l/email-protection#3a75726b7a525249145d554c"><span class="__cf_email__" data-cfemail="e4abacb5a48c8c97ca838b92">[email protected]</span></a>.
Written comments should not exceed three pages in length.
Individuals who need special assistance, such as sign language
interpretation or other reasonable accommodations, should indicate the
special accommodation when registering online or by notifying Jennifer
Gillissen at <a href="/cdn-cgi/l/email-protection#5f353a313136393a2d7138363333362c2c3a311f343e2a3939323e3136313c713c3032"><span class="__cf_email__" data-cfemail="b1dbd4dfdfd8d7d4c39fd6d8ddddd8c2c2d4dff1dad0c4d7d7dcd0dfd8dfd29fd2dedc">[email protected]</span></a> by August 30, 2021.
Authority: The National Clinical Care Commission is required under
the National Clinical Care Commission Act (Pub. L. 115-80). The
Commission is governed by provisions of the Federal Advisory Committee
Act (FACA), Public Law 92-463, as amended (5 U.S.C., App.) which sets
forth standards for the formation and use of federal advisory
committees.
Dated: July 14, 2021.
Dorothy A. Fink,
Deputy Assistant Secretary for Women's Health.
[FR Doc. 2021-15507 Filed 7-20-21; 8:45 am]
BILLING CODE 4150-32-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on July 21, 2021.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.